Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.

Adult volunteers received a booster dose (4 x 10(8) CFU) of attenuated Vibrio cholerae CVD 103-HgR oral vaccine 15 or 24 months after primary immunization. The immune response was modest, presumably due to rapid clearance of the vaccine strain by a primed immune system.

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Immun
Main Authors: Cryz, S J, Levine, M M, Losonsky, G, Kaper, J B, Althaus, B
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 1992
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC257409/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1500200/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.60.9.3916-3917.1992
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados